Opposite Modulatory Effects of Crataegus aronia Aqueous Extract on Platelet Aggregation in Rats
- PMID: 32418179
- DOI: 10.1007/s11655-020-3187-3
Opposite Modulatory Effects of Crataegus aronia Aqueous Extract on Platelet Aggregation in Rats
Abstract
Objectives: To reveal the mechanisms behind the dual effects of Crataegus aronia (C. aronia) aqueous extract on platelet aggregation by focusing on function, regulation, expression, and signaling of platelets P2Y12 receptors.
Methods: Adult male Wistar rats (120 ± 10 g) were classified as control received the vehicle, C. aronia (200 mg/kg), and C. aronia (2,000 mg/kg)-treated rats. After treatments for consecutive 7 days, hematological and molecular experiments were conducted to detect alterations in platelet aggregation, thromboxane B2 (THXB2) and intracellular reactive oxygen species (ROS) content; protein levels of P2Y12, p-Akt, cyclic adenosine monophosphate (cAMP), phosphorylated vasodilator-stimulated-phosphoprotein (p-VASP), nuclear factor κB (NF-κB), P-selectin, and etc. in platelets were determined by Western blot; mRNA expressions of P2Y12 and some inflammatory markers were determined by real-time polymerase chain reaction.
Results: At a concentration of 200 mg/kg, C. aronia inhibited platelet aggregation through multiple interconnected mechanisms including downregulation P2Y12 synthesis and expression, stimulating intracellular cAMP levels and protein levels of p-VASP, inhibiting platelets THXB2 release and protein levels of P-selectin. Also, it inhibited platelets level of ROS and of NF-κB, a major signaling pathway that stimulates the expression of P2Y12 and THXA2 synthesis. Opposite findings were seen in platelets of rats received C. aronia at a concentration of 2,000 mg/kg. Interestingly, co-administration of N-acetylcysteine prevented all hematological and molecular alterations exerted by the high dose of the extract and inhibited platelet aggregation.
Conclusion: Oral administration of C. aronia at low dose inhibits platelet aggregation by reducing THXB2 release, expression of P-selectin and activating cAMP and Akt signaling through two major mechanisms including downregulation of P2Y12 and inhibition of ROS-induced activation of NF-κB, an effect that is observed to be in the opposite direction with its high dose.
Keywords: Crataegus aronia; Intracellular cyclic adenosine monophosphate; P2Y12; aggregation; nuclear factor αB; platelets; reactive oxygen species.
© 2020. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.
References
Reference
-
- Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res 2004;114:447–453. - DOI
-
- Abdulla A, Awla D, Hartman H, Weiber H, Jeppsson B, Regner S, et al. Platelets regulate P-selectin expression and leukocyte rolling in inflamed venules of the pancreas. Eur J Pharmacol 2010;682:153–160. - DOI
-
- Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, Quinton TM. ADP receptors—targets for developing antithrombotic agents. Curr Pharm Des 2003;9:2303–16. - DOI
-
- Kim S, Kunapuli SP. P2Y12 receptor in platelet activation. Platelets 2011;22:54–58. - DOI
-
- Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli SP. Nucleotide receptor signaling in platelets. J Thromb Haemost 2006;4:2317–2326. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical